Rucaparib or Physician's Choice in Metastatic Prostate Cancer

Rucaparib provides better survival than usual care in metastatic prostate cancer - Hospital Pharmacy EuropeHospital Pharmacy Europe

Prostate Cancer Treatment & Management: Approach Considerations, Localized Prostate Cancer, Management of Advanced and Metastatic Disease

Prostate cancer and PARP inhibitors: progress and challenges, Journal of Hematology & Oncology

Prostate cancer

Evaluating the Role of Stereotactic Body Radiation Therapy With Respect to Androgen Receptor Signaling Inhibitors for Oligometastatic Prostate Cancer - Advances in Radiation Oncology

Platinum-based chemotherapy in metastatic prostate cancer: what possibilities?

Rucaparib Extends Progression-Free Survival in Selected Patients With Metastatic Castration-Resistant Prostate Cancer - The ASCO Post

Advanced Prostate Cancer: Treatment Advances and Future Directions: Trends in Cancer

Understanding the Current Therapeutic Landscape for Advanced Prostate Cancer

Both Olaparib and Rucaparib Demonstrate Efficacy for Metastatic Castration-Resistant Prostate Cancer

Role of rucaparib in the treatment of prostate cancer

Frontiers Applications for open access normalized synthesis in metastatic prostate cancer trials